Gepotidacin NDA Under Priority Review by FDA for Uncomplicated UTI
The FDA has accepted the New Drug Application (NDA) for investigational, first-in-class oral antibiotic gepotidacin, according to a press release from manufacturer GSK. The drug, which has a n...